Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other financing activities (2023 - 2026)

Kura Oncology has reported Other financing activities over the past 4 years, most recently at $69000.0 for Q1 2026.

  • Quarterly Other financing activities fell 51.75% to $69000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, down 75.23% year-over-year, with the annual reading at $1.8 million for FY2025, 79.16% down from the prior year.
  • Other financing activities was $69000.0 for Q1 2026 at Kura Oncology, down from $515000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $3.0 million in Q2 2024 and troughed at $69000.0 in Q1 2026.
  • The 4-year median for Other financing activities is $515000.0 (2025), against an average of $1.1 million.
  • Year-over-year, Other financing activities skyrocketed 2521.43% in 2024 and then tumbled 94.4% in 2025.
  • A 4-year view of Other financing activities shows it stood at $84000.0 in 2023, then soared by 860.71% to $807000.0 in 2024, then tumbled by 36.18% to $515000.0 in 2025, then crashed by 86.6% to $69000.0 in 2026.
  • Per Business Quant, the three most recent readings for KURA's Other financing activities are $69000.0 (Q1 2026), $515000.0 (Q2 2025), and $143000.0 (Q1 2025).